---
title: "APCINTEX LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a
json: https://whiteintel.dev/api/public/dossier/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a
identifier: oo:GB-COH-09088717
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# APCINTEX LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09088717`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a  

## Ownership & control

### Owners / controllers

- **CENTESSA PHARMACEUTICALS PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/e10d05fd-7fc1-5145-a4ed-00f5510bea05
- **APCINTEX LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a
- **CENTESSA PHARMACEUTICALS (UK) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/49b4bbab-6596-5297-9c2a-d9bb6ed51b20
- **Touchstone Innovations Businesses Llp** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/2b8b5dca-4317-4de0-978c-cac1ae9b1da3
- **CENTESSA PHARMACEUTICALS PLC** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/e10d05fd-7fc1-5145-a4ed-00f5510bea05

### UBO chain (walk to the ultimate owner)

A **9-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09088717`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2014-06-16
- **Registered office:** Lilly House Basingview, Basingstoke, Hampshire, RG21 4FA, United Kingdom
- **SIC:** 72110

### Officers

- [OAKWOOD CORPORATE SECRETARY LIMITED](https://whiteintel.dev/entity/1c359d14-ce8b-42da-aba0-13fad1c329e5) — corporate secretary · appointed 2021-11-30
- STOKES, Christopher J — director · American · appointed 2026-06-24
- WRIGHT, Kristina Mignon — director · American · appointed 2026-06-24
- [THE CAMBRIDGE PARTNERSHIP LIMITED](https://whiteintel.dev/entity/a04ad399-4001-5e4f-beb2-60e6b27a5f07) — corporate secretary · appointed 2014-06-16 · resigned 2021-11-01
- BACH GONZALEZ, Daniel, Dr — director · Spanish · appointed 2016-12-07 · resigned 2018-04-05
- BAGLIN, Trevor Patrick, Dr — director · British · appointed 2016-12-07 · resigned 2021-01-29
- CHAO, David Min — director · American · appointed 2021-11-30 · resigned 2025-07-04
- GRAINGER, David John, Dr — director · British · appointed 2014-06-16 · resigned 2016-12-07
- HUNTINGTON, James Andrew, Professor — director · British · appointed 2016-12-07 · resigned 2021-01-29
- HUSSAIN, Iqbal — director · British · appointed 2021-01-29 · resigned 2026-06-24
- JOHNSON, Kevin Stuart, Dr — director · British · appointed 2014-06-16 · resigned 2021-01-29
- MENZIUSO, Richard — director · American · appointed 2022-11-01 · resigned 2026-06-24
- SAHA, Saurabh, Dr — director · American · appointed 2021-01-29 · resigned 2021-11-30
- THORELL, Marella — director · American · appointed 2021-01-29 · resigned 2022-07-31
- WEINHOFF, Gregory Mark — director · American · appointed 2025-07-01 · resigned 2026-06-24
- YUE, Patrick — director · American · appointed 2023-08-17 · resigned 2024-06-21
- [IP2IPO SERVICES LIMITED](https://whiteintel.dev/entity/b21b9a75-76e8-5cdc-9da2-2bf770496dd4) — corporate director · appointed 2018-04-05 · resigned 2021-01-29

### Beneficial owners (Persons with Significant Control)

- [Centessa Pharmaceuticals (Uk) Limited](https://whiteintel.dev/entity/49b4bbab-6596-5297-9c2a-d9bb6ed51b20) — 75–100% shares · corporate PSC · United Kingdom — since 2022-12-20
- [Centessa Pharmaceuticals Plc](https://whiteintel.dev/entity/e10d05fd-7fc1-5145-a4ed-00f5510bea05) — 75–100% shares · corporate PSC · United Kingdom — ceased 2022-12-20
- Touchstone Innovations Businesses Llp — 25–50% shares · corporate PSC · England — ceased 2021-01-29

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09088717
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09088717

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **APCINTEX LIMITED** — https://whiteintel.dev/entity/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **APCINTEX LIMITED**. Human view: https://whiteintel.dev/entity/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a · Structured JSON: https://whiteintel.dev/api/public/dossier/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._